ArticleTrauma (London, England)2019

A one-year cost-utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage.

Maxwell S Renna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.